FFR è un nuovissimo modello matematico che potrebbe essere utile in ambito medico per calcolare l'aterosclerosi coronarica stenotica . La misura dell'affidabilità (facilmente riproducibile) tra laboratori concorrenti per testare questa metrica cruciale è ancora in discussione in una gara proprietaria che afferma la matematica cardiaca basata sul rischio per la cardiopatia ischemica.
Il flusso sanguigno verso una particolare parte del corpo viene misurato utilizzando una procedura di riserva di flusso frazionaria. I pazienti ricevono un'iniezione di materiale radioattivo prima della procedura, che verrà utilizzata per visualizzare il flusso sanguigno in una particolare area del corpo. Dopo l'imaging, viene praticata una piccola incisione, viene misurato il flusso sanguigno e viene somministrato un anestetico locale.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (milioni di USD) |
| Segmentazione | Per tipo, per tecnologia, per applicazione, per regione. |
| Per tipo |
|
| Per tecnologia |
|
| Per applicazione |
|
| Per regione |
|
Si sta aumentando la spesa per la ricerca e lo sviluppo (R&S) per creare nuove apparecchiature che siano convenienti ed efficienti, dato che aumentano i casi di malattie cardiovascolari come l'ipertensione e le malattie coronariche. Secondo l'OMS, nel 2021 sono morte 17,9 milioni di persone per malattie cardiovascolari, ovvero circa il 31% di tutti i decessi in tutto il mondo.
Un FFR è una procedura non invasiva utilizzata per valutare la malattia coronarica (CAD) nei pazienti con stenosi delle arterie coronarie. Il test della riserva di flusso frazionario è un esame del sangue che misura la pressione arteriosa.
Si prevede che la crescente popolazione geriatrica aumenterà la domanda di riserva di flusso frazionato. Gli individui di età superiore ai 65 anni sono più vulnerabili alle malattie cardiovascolari e alle malattie croniche come il diabete. Il diabete di tipo II può anche portare alla formazione di cellule grasse nell'arteria coronaria, che possono causare un blocco e, di conseguenza, un ictus o un infarto. A causa dei baby boomer tardivi in paesi come Giappone, Cina e Brasile, tra gli altri, si prevede che la popolazione geriatrica globale crescerà in modo esponenziale nei prossimi anni. Le Nazioni Unite hanno stimato che la popolazione di persone di età pari o superiore a 65 anni fosse di 703 milioni nel 2019, con una cifra che dovrebbe raddoppiare a 1,5 miliardi entro il 2050.
La riduzione dei servizi e delle procedure cardiovascolari causata dalla pandemia di COVID-19 ha avuto un impatto considerevole sull'espansione del mercato. Tuttavia, è stato consigliato ai pazienti cardiovascolari di continuare la terapia FFR per aumentare le loro possibilità di sopravvivenza e gestire meglio la capacità del loro sistema immunitario di respingere il virus SARS-CoV-2. Secondo l'analisi, questi eventi hanno aiutato il mercato a crescere durante la pandemia e si prevede che lo faranno di nuovo nei prossimi anni.
Una valutazione FFR non può distinguere tra coronaropatia, spasmo coronarico o stenosi coronarica. Un altro inconveniente è la capacità di una valutazione di essere influenzata da elementi esterni come pressione sanguigna e frequenza cardiaca. Inoltre, la misurazione potrebbe dover essere più accurata per determinate persone o pazienti con coronaropatia. Il test è anche costoso, invasivo e appropriato solo per alcuni pazienti.
The fractional flow reserve market reached USD 671.40 million in 2020 and is expected to grow at a CAGR of more than 11.2% through 2029, owing to the increasing in awareness about health.
The upcoming trend in the fractional flow reserve market is an opportunity for market growth.
The global fractional flow reserve market registered a CAGR of 11.2% from 2022 to 2029.
Key players profiled in the report include OPSENS Medical, Abbott Laboratories, Koninklijke Philips N.V., Acist Medical Systems Inc., Boston Scientific, Medtronic plc, B. Braun Melsungen, Siemens, Terumo Medical Corporation and Medis Medical Imaging System.
The North America fractional flow reserve market had largest market share of 37% in 2021. The dominance of the region can be attributed to favorable government policies for medical device penetration and the presence of well-developed healthcare infrastructure. In addition, rising mergers and acquisitions by key players are poised to keep the level of competition high in the near future.
The introduction of technologically advanced monitoring systems is expected to drive profitable growth in the FFR monitoring systems segment during the forecast period. Due to their widespread use in diagnostic cardiovascular procedures, FFR guidewires held a commanding 58.06% market share in 2021. This segment is expected to grow at a healthy CAGR during the forecast period due to increased use for coronary artery disease diagnosis globally. According to the Centers for Disease Control and Prevention (CDC), approximately 360,900 people died in the United States in 2019 as a result of coronary artery disease. Furthermore, the elderly is more vulnerable to cardiac problems. As a result, the segment's growth is aided by the segment's expanding base.
Technology-based categories for invasive and non-invasive monitoring make up the fractional flow reserve market. In 2021, the non-invasive segment held the largest market share in the fractional flow reserve market due to the low risk of procedural complications and the availability of clinical evidence demonstrating its efficacy. For assessing the hemodynamic effects of coronary lesions, invasive FFR monitoring is regarded as the gold standard. For the purpose of measuring fractional flow reserve, this technology makes use of pressure guidewires and monitoring systems. The blood flow and pressure before and after the blockage are measured by the pressure guidewire to create a ratio.
Invasive fractional flow reserve systems are widely used to assess lesion-specific ischemic in patients with 50% to 90% stenosis. The invasive segment has made only modest progress. One of the main causes of the slower adoption of non-invasive FFR systems is that many clinicians continue to think that angiography yields superior results and that this will be sufficient to determine the patients' treatment course. The diagnostic procedures are also left up to the discretion of the local practitioners, though many still favour CT scans, nuclear tests, and invasive angiography.
As a more advanced form of single-vessel CAD, the multi-vessel coronary artery disease (CAD) segment is anticipated to register a higher CAGR during the forecast period. If proper care and medication are not taken, a person with single-vessel CAD is very likely to develop multi-vessel CAD in the near future. Due to the widespread use of the device in CAD and the growing elderly population, the single-vessel coronary artery disease (CAD) segment dominated the fractional flow reserve market in 2021 with a share of over 50.04%.
[caption id="attachment_23491" align="aligncenter" width="1920"]
Key players involved in fractional flow reserve market are OPSENS Medical, Abbott Laboratories, Koninklijke, Philips N.V., Acist Medical Systems Inc., Boston Scientific, Medtronic plc, B. Braun Melsungen, Siemens, Terumo Medical Corporation and Medis Medical Imaging System. Mergers and acquisitions, joint ventures, capacity expansions, significant distribution, and branding decisions by established industry players to boost market share and regional presence. They are also engaged in continuous R&D activities to develop new Product Products and are focused on expanding the Product type portfolio. This is expected to increase competition and pose a threat to new market entrants.
Geographically, the Fractional Flow Reserve market is segmented into North America, South America, Europe, APAC and MEA.
Due to the growing geriatric population linked to cardiovascular diseases and the growing technological advancements in FFR monitoring devices, North America is anticipated to hold a significant market share in the fractional flow reserve market. The global fractional flow reserve market was dominated by the United States. The United States has become a major fractional flow reserve market shareholder due to the faster adoption of value-based products in the healthcare system, increased clinician awareness, and increasing adoption of FFR-CT.
The market for fractional flow reserves is anticipated to experience profitable growth in the Asia Pacific region over the next few years as a result of an increase in diabetes and cardiovascular disease cases as well as rising disposable income. Additionally, it is anticipated that the adoption of laws that are favorable to medical device adoption will support the expansion of the regional market.
Values-based and volume-based healthcare providers coexist in Europe's healthcare system. The value-based treatment providers adopt it more quickly. Some of the developing economies in Europe have a low rate of adoption of cutting-edge technologies. The usage of cutting-edge products and the growth of the non-invasive fractional flow reserve market are primarily driven by the rising number of CATH Labs and office-based labs.
The nations of Latin America are renowned as places to receive various medical treatments. Urban hospitals use a lot of cutting-edge technology to draw tourists. Due to a lack of reimbursement, local patients rarely use this service and instead choose to undergo more expensive market tests. Additionally, the market's reliance on traditional methods is constrained by a lack of trained lab technicians.
[caption id="attachment_23492" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.